ZURA BIO LIMITED Preferred Stock, Shares Outstanding
ZURA BIO LIMITED (ZURA) had Preferred Stock, Shares Outstanding of 0 shares as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2025-11-13
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 0.00 shares 10-Q · filed 2025-11-13 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 0.00 shares 10-Q/A · filed 2022-04-25 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-27 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |